Mohamed Sherif Salem/LinkedIn
Mar 16, 2026, 17:42
Mohamed Sherif Salem: Turning 2026 KDIGO Complexity into Bedside Clarity
Mohamed Sherif Salem, Senior Clinical Pharmacist at Andalusia Health Egypt, shared on LinkedIn:
“Turning 2026 KDIGO Complexity into Bedside Clarity.
The new KDIGO 2026 Anemia Guidelines offer vital clinical insights, but navigating high-density data during a busy shift isn’t always easy.
I used AI to extract the core thresholds and monitoring frequencies into this bedside-ready infographic.
What’s inside:
- Clear initiation thresholds for HD, ND-CKD, and PD.
- ‘Stop’ triggers to prevent iron overload.
- Simplified pathophysiology terminology.
- Required monitoring intervals by CKD stage.
I hope this acts as a helpful quick-reference tool.
Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. (2026). KDIGO 2026 clinical practice guideline for the management of anemia in chronic kidney disease. Kidney International, 109(2S), S1–S120″
Stay updated with Hemostasis Today.
-
Mar 16, 2026, 17:39Julie Cardoso: What Happens to Venous Valves When a Blood Clot Forms?
-
Mar 16, 2026, 17:38Nasir Jamal: Blood Transfusion Criteria and Hemodialysis Thresholds in ESRD Patients
-
Mar 16, 2026, 17:37Octavio Cosín Sales: Understanding the Influence of Systemic Factors on Chronic Venous Insufficiency
-
Mar 16, 2026, 17:35Shiny K. Kajal: From Simple Calcium Chelation to Full-Blown Red Cell Metabolic Engineering
-
Mar 16, 2026, 17:12Cold-Stored vs Room-Temperature Platelets in Trauma-Induced Coagulopathy – JTH
-
Mar 16, 2026, 17:10Arturo Cesaro: First Meta-Analysis on the Vascular Protective Role of Semaglutide in PAD
-
Mar 16, 2026, 17:01Jeff Sternlicht: The Most Powerful Time to Lower Cholesterol Is Before Anyone Thinks You Need It
-
Mar 16, 2026, 16:14Siobhan Calafiore: Clinical Advantages of Apixaban Over Rivaroxaban in Reducing Bleeding Risk
-
Mar 16, 2026, 16:12Nuha El Sayed: Focused Summary of the 2026 ACC/AHA Guideline on Management of Dyslipidemia in Diabetes